“It’s almost here! The t:slim X2 insulin pump integration with the FreeStyle Libre 3 Plus sensor, the world’s smallest continuous glucose monitor, is coming soon,” Tandem wrote on LinkedIn.
Tandem announced that it was pairing its t:slim X2 automated insulin delivery system with Libre 3 Plus in June. At the time, the company said it had already initiated an early access program for integration in the U.S. with plans to scale availability in the second half of 2025.
On Tandem’s website, it says the pump will integrate with the FreeStyle Libre 3 Plus “by the end of 2025.”
The pending rollout would provide the latest pairing of automated insulin delivery (AID) and continuous glucose monitor (CGM) technologies between the companies. They announced the integration of FreeStyle Libre 2 Plus CGM into the t:slim X2 insulin pump in January 2024. Just last week, the companies announced the future pairing of Tandem systems with Abbott’s under-development dual glucose-ketone sensor.
Abbott’s FreeStyle Libre 3 Plus is the company’s latest-generation CGM designed for insulin pump integration. Its readings every minute can help insulin pumps adjust to users’ needs. The system also offers a 15-day wear time.
t:slim X2, powered by Control-IQ+ technology, has an advanced hybrid closed-loop automated insulin delivery feature. It predicts and helps prevent high and low blood sugar. Control-IQ leads to improved time in range throughout the day and night. Tandem unveiled the next-generation algorithm earlier this year.
